Literature DB >> 25065689

Anti-inflammatory activity of iridoid and catechol derivatives from Eucommia ulmoides Oliver.

Dan Luo1, Terry C T Or, Cindy L H Yang, Allan S Y Lau.   

Abstract

Neuroinflammation and pro-inflammatory mediators play key roles in the pathogenesis of neurodegenerative diseases including stroke, which account for a significant burden of morbidity and mortality worldwide. Recently, the unsatisfactory pharmacotherapy and side effects of the drugs led to the development of alternative medicine for treating these diseases. Du Zhong (DZ), Eucommia ulmoides Oliver leaves, is a commonly used herb in the therapy of stroke in China. We hypothesize that the components from DZ inhibit neuroinflammation. In this study, DZ was extracted and the bioactive fractions with inhibitory effect on lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production in BV-2 microglial cells were further separated using chromatography. Two purified bioactive compounds, genipin (compound C) and 4-(1,2-dimethoxyethyl)benzene-1,2-diol (compound F), were isolated and identified after spectroscopic analysis. The results showed that they inhibited LPS-stimulated NO and tumor necrosis factor-alpha (TNF-α) production. Genipin exerted its anti-inflammatory effects through PI3K/Akt signaling pathway, whereas compound F inhibited phosphorylation of p38 mitogen-activated protein kinase (MAPK). In conclusion, genipin and compound F have potential for developing into new drugs for treating neurodegenerative diseases.

Entities:  

Keywords:  4-(1,2-dimethoxyethyl)benzene-1,2-diol; Eucommia ulmoides Oliver; Neuroinflammation; genipin; neurodegenerative diseases

Mesh:

Substances:

Year:  2014        PMID: 25065689     DOI: 10.1021/cn5001205

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  9 in total

Review 1.  Therapeutic Potential of Genipin in Central Neurodegenerative Diseases.

Authors:  Yanwei Li; Lin Li; Christian Hölscher
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

2.  Multilayered Thin Films from Boronic Acid-Functional Poly(amido amine)s As Drug-Releasing Surfaces.

Authors:  Sry D Hujaya; Johan F J Engbersen; Jos M J Paulusse
Journal:  Pharm Res       Date:  2015-06-26       Impact factor: 4.200

3.  Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.

Authors:  Jiqu Xu; Congcong Ma; Meng Chen; Shuang Rong; Hui Gao; Zumeng Xia; Fenghong Huang
Journal:  Lipids Health Dis       Date:  2018-07-31       Impact factor: 3.876

Review 4.  Neuroendocrine-Immune Regulatory Network of Eucommia ulmoides Oliver.

Authors:  Yi Zhao; De-Chao Tan; Bo Peng; Lin Yang; Si-Yuan Zhang; Rui-Peng Shi; Cheong-Meng Chong; Zhang-Feng Zhong; Sheng-Peng Wang; Qiong-Lin Liang; Yi-Tao Wang
Journal:  Molecules       Date:  2022-06-08       Impact factor: 4.927

5.  Pyrocatechol Alleviates Cisplatin-Induced Acute Kidney Injury by Inhibiting ROS Production.

Authors:  Xuexia Xie; Fan Wu; Jiaxin Tian; Zhilong Liu; Huibin He; Dongping Bao; Guoliang Li; Haomin Li; Jianfan Chen; Yiqi Lai; Zheng Chen; Jun Fan; Guo Chen; Caiyong Lai
Journal:  Oxid Med Cell Longev       Date:  2022-09-19       Impact factor: 7.310

6.  The Aqueous Extract of Eucommia Leaves Promotes Proliferation, Differentiation, and Mineralization of Osteoblast-Like MC3T3-E1 Cells.

Authors:  Mengqi Guan; Daian Pan; Mei Zhang; Xiangyang Leng; Baojin Yao
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-19       Impact factor: 2.629

7.  Quercitrin for periodontal regeneration: effects on human gingival fibroblasts and mesenchymal stem cells.

Authors:  Manuel Gómez-Florit; Marta Monjo; Joana M Ramis
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

Review 8.  Chronic over-nutrition and dysregulation of GSK3 in diseases.

Authors:  Xunxian Liu; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2016-08-04       Impact factor: 4.169

9.  Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles.

Authors:  Gang Deng; Chao Ma; Haitian Zhao; Shenqi Zhang; Jun Liu; Fuyao Liu; Zeming Chen; Ann T Chen; Xin Yang; Jonathan Avery; Pan Zou; Fengyi Du; Keun-Poong Lim; Daniel Holden; Songye Li; Richard E Carson; Yiyun Huang; Qianxue Chen; W Taylor Kimberly; J Marc Simard; Kevin N Sheth; Jiangbing Zhou
Journal:  Theranostics       Date:  2019-09-21       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.